NY A10991

The Office of Alcoholism and Substance Abuse Services, in consultation with the Department of Health, must maintain a publicly available online directory of opioid antagonist distributors including pharmacies, prevention programs, and not-for-profits.

"Opioid antagonist" is defined as an FDA-approved drug that negates or neutralizes opioid effects, limited to naloxone or other medications approved by the Department of Health.

The directory must be searchable by distributor addresses, contact information, services offered, opioid antagonists available, special populations served, accepted insurance providers, hours of operation, and opioid addiction prevention program contacts.

The Office may utilize an existing directory to satisfy these requirements.

The act takes effect 180 days after becoming law, with rule and regulation changes authorized to be completed by the effective date.